Prostate health index significantly reduced unnecessary prostate biopsies in patients with PSA 2-10 ng/mL and PSA >10 ng/mL: Results from a Multicenter Study in China-Reference-Cited by-同舟云学术

Prostate health index significantly reduced unnecessary prostate biopsies in patients with PSA 2-10 ng/mL and PSA >10 ng/mL: Results from a Multicenter Study in China

Published:2017-06-30 Issue:11 Volume:77 Page:1221-1229
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Na Rong¹²³⁴⁵,Ye Dingwei⁶,Qi Jun⁷,Liu Fang²,Helfand Brian T.⁸,Brendler Charles B.⁸,Conran Carly A.³,Packiam Vignesh⁸,Gong Jian²,Wu Yishuo¹²,Zheng Siqun L.³,Mo Zengnan⁹,Ding Qiang¹²,Sun Yinghao¹⁰,Xu Jianfeng²³^ORCID

Affiliation:

1. Department of Urology; Huashan Hospital, Fudan University; Shanghai PR China

2. Fudan Institute of Urology, Huashan Hospital; Fudan University; Shanghai PR China

3. Program for Personalized Cancer Care; NorthShore University HealthSystem; Evanston Illinois

4. Department of Surgery, Pritzker School of Medicine; University of Chicago; Chicago Illinois

5. Fudan Universtiy Shanghai Medical College; Shanghai PR China

6. Department of Urology, Shanghai Cancer Center; Fudan University; Shanghai PR China

7. Department of Urology, Xinhua Hospital; Shanghai Jiaotong University School of Medicine; Shanghai PR China

8. Division of Urology; NorthShore University HealthSystem; Evanston Illinois

9. Center for Genomic and Personalized Medicine; Guangxi Medical University; Nanning Guangxi PR China

10. Department of Urology, Shanghai Changhai Hospital; The Second Military Medical University; Shanghai PR China

Funder

Shanghai Hospital Development Center

the National Key Basic Research Program Grant 973 of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Urology,Oncology

Reference22 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. The updated incidences and mortalities of major cancers in China, 2011;Chen;Chin J Cancer,2015

3. Trends of prostate cancer incidence and mortality in Shanghai, China from 1973 to 2009;Qi;Prostate,2015

4. Mortality results from the Goteborg randomised population-based prostate-cancer screening trial;Hugosson;Lancet Oncol,2010

5. Overdiagnosis and overtreatment of prostate cancer;Loeb;Eur Urol,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic value comparison of the combination of prostate-specific membrane antigen-body PET/MR and the prostate health index with each alone in early diagnosis of prostate cancer;Asian Journal of Urology;2024-02

2. Diagnostic Accuracy of Liquid Biomarkers for Clinically Significant Prostate Cancer Detection: A Systematic Review and Diagnostic Meta-analysis of Multiple Thresholds;European Urology Oncology;2023-11

3. The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy;Journal of Clinical Medicine;2023-02-08

4. A prospective study of the prostate health index density and multiparametric magnetic resonance imaging in diagnosing clinically significant prostate cancer;Investigative and Clinical Urology;2023

5. Molecular Biomarkers for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis;European Urology Open Science;2022-12